Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Sale of product	$ 2,434,808	$ 2,759,896	$ 5,242,249	$ 4,752,408
Cost of product	1,034,278	1,171,968	2,164,976	2,003,322
Gross profit	1,400,530	1,587,928	3,077,273	2,749,086
Operating costs and expenses:
Salaries and contract labor	801,972	625,428	1,735,221	1,293,948
General, administrative and consulting	863,025	875,799	1,776,148	1,781,728
Research and development	87,642	71,979	294,056	109,216
Total operating expenses	1,752,639	1,573,206	3,805,425	3,184,892
Net operating loss	(352,109)	14,722	(728,152)	(435,806)
Other income (expense):
Other income	225,768	32,356	2,028,568	175,476
Interest income	680	46	725	81
Interest expense	(146,387)	(211,456)	(318,144)	(409,747)
Total other income (expense)	80,061	(179,054)	1,711,149	(234,190)
Net income (loss)	(272,048)	(164,332)	982,997	(669,996)
Income attributable to noncontrolling interest		17,055		112,543
Net income (loss) attributable to International Isotopes Inc.	$ (272,048)	$ (181,387)	$ 982,997	$ (782,539)
Net income per common share - basic:
Net income per common share -  diluted:
Weighted average common shares outstanding - basic	510,499,497	460,798,173	506,985,962	457,123,946
Weighted average common shares outstanding - diluted	510,499,497	460,798,173	512,569,114	457,123,946